Safety and Efficacy of the Novel OmniaSecure Defibrillation Lead Through Long-Term Follow-Up: Final Results From the LEADR Trial

20252 citationsJournal Articlehybrid Open Access

Authors

George H. Crossley · Vanderbilt University Medical Center

Prashanthan Sanders · Royal Adelaide Hospital

Bert Hansky · Klinikum Bielefeld

Paolo De Filippo · Ospedale Papa Giovanni XXIII

Maully J. Shah · Children's Hospital of Philadelphia

Surinder Kaur Khelae · National Heart Institute

Travis D. Richardson

Abstract

The final results of the LEADR trial demonstrated 3-year term safety, efficacy, and reliability of the OmniaSecure lead, emphasizing the potential utility of this lead in a wide variety of patients.

Topics & Keywords

Cardiac pacing and defibrillation studies Neurological disorders and treatments Cardiovascular Syncope and Autonomic Disorders

Publication Details

Published in: Circulation Arrhythmia and Electrophysiology

Volume 19, Issue 1, pp. e014424-e014424

DOI: 10.1161/circep.125.014424

Field-Weighted Citation Impact: 3.04

Command Palette

Safety and Efficacy of the Novel OmniaSecure Defibrillation Lead Through Long-Term Follow-Up: Final Results From the LEADR Trial

Authors

Abstract

Topics & Keywords

Publication Details